| Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
| Tel: |
821-50328103-801 18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:Macbecin I;(15R)-6,17-DideMethoxy-15-Methoxy-6-Methyl-11-O-Methyl-geldanaMycin
CAS:73341-72-7
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
| Company Name: |
EMMX Biotechnology LLC
|
| Tel: |
888-539-0666 |
| Email: |
info@emmx.com |
| Products Intro: |
Product Name:Macbecin I
CAS:73341-72-7
Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:Macbecin I
CAS:73341-72-7
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
MedBioPharmaceutical Technology Inc
|
| Tel: |
021-69568360 18916172912 |
| Email: |
order@med-bio.cn |
| Products Intro: |
Product Name:macbecin I
CAS:73341-72-7
Purity:98% Package:1mg Remarks:Medbio
|
|
| | macbecin I Basic information |
| Product Name: | macbecin I | | Synonyms: | macbecin I;(6S,15R)-6,17-Didemethoxy-15-methoxy-6-methyl-11-O-methylgeldanamycin;(15R)-6,17-Didemethoxy-15-methoxy-6-methyl-11-O-methyl-geldanamycin;Geldanamycin, 6,17-didemethoxy-15-methoxy-6-methyl-11-O-methyl-, (15R)-;Macbecin | | CAS: | 73341-72-7 | | MF: | C30H42N2O8 | | MW: | 558.67 | | EINECS: | | | Product Categories: | | | Mol File: | 73341-72-7.mol |  |
| | macbecin I Chemical Properties |
| Melting point | 205-206 °C(Solv: ethanol (64-17-5); water (7732-18-5)) | | Boiling point | 736.2±60.0 °C(Predicted) | | density | 1.17±0.1 g/cm3(Predicted) | | storage temp. | Desiccate at -20°C | | solubility | Soluble in DMSO > 10 mM | | form | Powder | | pka | 8.62±0.70(Predicted) |
| | macbecin I Usage And Synthesis |
| Uses | Macbecin I is an ansamycin antibiotic inhibitor of Hsp90 activity. | | Biological Activity | Ansamycin antibiotic compound that inhibits Hsp90 activity (IC 50 = 2 μ M) by binding to the ATP-binding site. Exhibits antitumor and cytocidal activities (IC 50 ~ 0.4 μ M) by causing degradation of key oncogenic client proteins such as ErbB2 and cRaf1. Displays higher affinity and potency than geldanamycin (9,13-Dihydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-carbamate ). |
| | macbecin I Preparation Products And Raw materials |
|